The recent article by Ildarabadi et al. [1], “Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial,” published in Osong Public Health Research Perspectives (2024), highlights the potential benefits of green coffee in addressing metabolic and oxidative stress-related aspects of polycystic ovary syndrome (PCOS). This compelling research inspires further exploration into the intricate relationships among PCOS, cardiovascular risk, and coffee consumption.
Mattioli, A.V. (2025). Polycystic ovary syndrome, cardiovascular risk, and coffee: a complex interplay. OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 16(1), 89-90 [10.24171/j.phrp.2025.0004].
Polycystic ovary syndrome, cardiovascular risk, and coffee: a complex interplay
Mattioli, Anna Vittoria
Primo
Conceptualization
2025
Abstract
The recent article by Ildarabadi et al. [1], “Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial,” published in Osong Public Health Research Perspectives (2024), highlights the potential benefits of green coffee in addressing metabolic and oxidative stress-related aspects of polycystic ovary syndrome (PCOS). This compelling research inspires further exploration into the intricate relationships among PCOS, cardiovascular risk, and coffee consumption.| File | Dimensione | Formato | |
|---|---|---|---|
|
j-phrp-2025-0004 policystic.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
164.75 kB
Formato
Adobe PDF
|
164.75 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
